?
DRJDent Res JDental Research JournalDental Research Journal
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Background:
This study aimed to assess the effect of local injection of injectable platelet-rich fibrin (i-PRF) on bone remodeling during orthodontic tooth movement in dogs.
Materials and Methods:
In this animal study, the maxillary first premolars of four adult male mixed-breed dogs were bilaterally extracted, and a nickel–titanium closed coil spring with 150 g force was placed between the canine and second premolar teeth. One quadrant of the maxilla was randomly selected as the test quadrant, and 0.5 cc i-PRF was injected into the periodontal ligament (PDL) around the second premolar at 1, 21, and 42 days. The other quadrant served as the control group and received saline injections. The dogs were sacrificed after 63 days, histological sections were prepared, and changes in bone remodeling were assessed by comparing the percentage of osteogenesis and number of osteoblasts and osteoclasts between the two groups by the Wilcoxon and Mann–Whitney U-tests (α = 0.05).
Results:
The percentage of osteogenesis (16.0% ± 4.96% in i-PRF and 13.5% ± 4.43% in the control), the percentage of newly formed lamellar bone (10.25% ± 2.87% in i-PRF and 8.75% ± 2.36% in the control), the percentage of woven bone (5.75% ± 2.21% in i-PRF and 4.75% ± 2.36% in the control), the number of osteoblasts (15.0 ± 3.46 in i-PRF and 11.75 ± 2.36 in the control), and the number of osteoclasts (11.25 ± 4.34 in i-PRF and 6.25 ± 2.62 in the control) were not significantly different between the two groups (P > 0.05).
Conclusion:
PDL injection of i-PRF around the second premolars of dogs under orthodontic force had no significant effect on bone remodeling.
Bone remodelingplatelet-rich fibrintooth movement techniquesIntroduction
Orthodontic treatments are based on the principles of biomechanics, and it is, in fact, the biological response to the applied forces that cause orthodontic tooth movement (OTM).
1Load application to the teeth causes bone remodeling, which includes periods of bone resorption and bone formation at the pressure and tension sides around each tooth, eliciting an acute inflammatory response in periodontal tissues.
2
OTM in the presence of a mechanical stimulus causes remodeling of the alveolar bone and periodontal ligament (PDL).
3Bone remodeling involves bone resorption at the pressure site and osteogenesis at the tension site.
4The magnitude of OTM can be controlled by the magnitude of applied force and biological responses of the PDL. The forces applied to the teeth cause some changes in the PDL, alter the blood flow, and induce the release of several inflammatory markers such as cytokines, growth factors, neurotransmitters, and arachidonic acid metabolites, which lead to bone remodeling.
5,
6OTM includes three phases: the first phase is characterized by fast OTM following load application, the second phase is a delayed phase with insignificant or no OTM, and the third phase is characterized by a gradual or sudden increase in OTM.
The application of platelet-rich plasma (PRP) for bone regeneration was introduced in the late 1990s. It was later used for orthopedic and oral surgical procedures. However, controversy still exists regarding the positive effects of PRP on osteogenesis.
7PRP contains high concentrations of autologous platelets in a small volume of autologous plasma (minimum of 1,000,000 platelets/μL in 5 mL of plasma). The platelets present in this autologous plasma concentrate release alpha granules after coagulation at the wound site. Alpha granules contain a group of growth factors that cause cell proliferation and differentiation and are imperative for osteogenesis. Thus, in addition to coagulative effects, PRP is a rich source of growth factors that play a role in the enhancement of wound healing, bone regeneration, and proliferation of fibroblasts. The PRP gel is prepared by mixing PRP (obtained by centrifugation of autologous whole blood) with thrombin and calcium chloride. The addition of thrombin and calcium chloride to PRP automatically induces the alpha granules to release biological growth factors such as platelet-derived growth factor (PDGF), transforming growth factor β (TGF-β), vascular endothelial growth factor (VEGF), and epidermal growth factor.
8
Platelet-rich fibrin (PRF) is a modified form of PRP. PRF is the second-generation platelet concentrate that was first introduced by Choukroun and Ghanaati,
9in France. It is an autogenous fibrin matrix that contains PDGF, leukocytes, and cytokines. The mechanism of action of PRF is through induction of proliferation of residual cells and bone regeneration. PRF has increased alkaline phosphatase activity in vitro. The release pattern of PDGF and TGF-β varies between PRP and PRF. In PRP, the release of such factors significantly decreases after the 1
stday; however, PRF continues to release such factors in considerable amounts for up to 2 weeks.
10Dohan Ehrenfest et al.
11confirmed a difference in the release profile of VEGF from leukocytes in the use of PRP compared with PRF. In total, it appears that the PRF membrane can release higher amounts of growth factors over longer periods of time.
12The injectable PRF (i-PRF) is the liquid form of PRF, which is obtained by low-speed centrifugation. I-PRF has advantages such as a high number of regenerative cells and high amounts of growth factors.
9
Orthodontic treatments depend on OTM, and injection of PRP and PRF is believed to enhance OTM. The advantages of PRF compared with PRP include a one-step preparation process, the addition of no chemicals like anticoagulants, faster preparation, and simpler application.
13
On the other hand, the duration of orthodontic treatment plays an important role in patient cooperation and periodontal status. Thus, attempts are ongoing to shorten the course of orthodontic treatment by acceleration of OTM. The application of PRF is a relatively novel modality for the acceleration of OTM. Thus, this study aimed to assess the effect of local injection of i-PRF on bone remodeling during OTM in dogs.
Materials and Methods
This animal study was conducted on four adult male mixed-breed dogs between 10 and 12 months of age. The study was conducted in accordance with the guidelines for the care and use of laboratory animals. The study protocol was approved by the Ethics Committee of the School of Dentistry, Islamic Azad University, Khorasgan Branch (IR.IAU.YAZD.REC.1400.168).
Sample size
The sample size was calculated to be four in each group according to a previous study,
14assuming α = 0.05, β = 0.2, and a study power of 80%.
Eligibility criteria
Adult male mixed-breed dogs between 10 and 12 months of age and 15–20 kg weight were included.
Intervention
After the induction of general and local anesthesia, the maxillary first premolars of the dogs were bilaterally extracted, and nickel–titanium closed coil springs (G&H Wire Co.) were used to connect the canine to the second premolar. To determine the proper length of the spring, the load of the spring was measured by a force meter (Dentaurum, Germany) to ensure the application of a 150 g load in this distance. Periapical radiographs were obtained from the teeth to ensure healthy PDL. Next, one quadrant of the maxilla was randomly selected as the test group, and 0.5 cc of i-PRF was injected at 8 points of mid-buccal, mid- lingual, distobuccal, distolingual, mid-distal, mesiolingual, mesiobuccal, and mid-mesial into the PDL around the second premolar. The other quadrant of the maxilla served as the control group and received 0.5 cc saline injections. Injections were performed at 1, 21, and 42 days after the placement of closed coil springs. The dogs were fed soft food during the study.
Preparation of injectable platelet-rich fibrin
Blood samples were obtained from the cephalic vein and collected in 10 cc test tubes without an anticoagulant. They were centrifuged (IntraSpin) at 700 rpm for 3 min with 60 g RCF. Next, 0.5 cc of the supernatant was collected by a syringe.
After 63 days, the dogs were sacrificed, the maxillae were resected, fixed in 10% formalin (Merck, Germany) for 48 h, and were then placed in 10% formic acid for 1 week. They were then dehydrated using graded concentrations of alcohol, embedded in paraffin, and sectioned by a microtome (Leica, RM 2035, Germany) into 5-μm slices. Five discs were obtained from the apical third of each premolar tooth (20 test and 20 control specimens in total). The slides were stained with hematoxylin and eosin (Merck, Germany) and observed under a light microscope (BX; Olympus) at ×100 and ×400. The changes in bone were assessed. The percentage of osteogenesis, the percentage of lamellar and woven bones, and the number of osteoblasts and osteoclasts were measured on five slides of each premolar tooth using Adobe Photoshop 7 software (San Jose, CA, USA), and the mean values were calculated and reported.
Statistical analysis
Data were analyzed by SPSS version 26 (SPSS Inc., IL, USA). Due to the small sample size, the normality of data distribution was analyzed by the evaluation of skewness and kurtosis, which showed nonnormal data distribution. Thus, the two groups were compared regarding the percentage of osteogenesis, percentage of lamellar and woven bones, and number of osteoblasts and osteoclasts by the Wilcoxon and Mann–Whitney U nonparametric tests at a 0.05 level of significance.
Results
Figure 1,
Figure 2,
Figure 3show osteogenesis, osteoblasts, and osteoclasts in the two groups.
Table 1presents the percentage of bone formation, lamellar bone and woven bone, and the number of osteoblasts and osteoclasts in the two groups.
Photomicrograph of a transverse tooth section, indicating normal cementum, dentin, periodontal ligament, and alveolar bone in the control group (H and E, ×100). PDL: Periodontal ligament, D: Dentin, AB: Alveolar bone.
Figure 1
Photomicrograph of a transverse tooth section, indicating dentin, osteoclasts, osteoblasts, bone resorption, cementum resorption, and alveolar bone in the PR group (H and E, ×100). D: Dentin, OC: Osteoclasts, OB: Osteoblasts, BR: Bone resorption, CR: Cementum resorption.
Figure 2
Photomicrograph of a transverse tooth section, indicating alveolar bone, periodontal ligament, osteoblasts, and dentin in the PRF group (H and E, ×100). PDL: Periodontal ligament, D: Dentin, OB: Osteoblasts, AB: Alveolar bone.
Figure 3{Table 1}
The percentage of osteogenesis (P = 0.581), the percentage of newly formed lamellar bone (P = 0.461), the percentage of woven bone (P = 0.593), the number of osteoblasts (P = 0.109), and the number of osteoclasts (P = 0.068) were not significantly different between the two groups.
Discussion
This study assessed the effect of local injection of i-PRF on bone remodeling during OTM in dogs. The results showed no significant difference between the two groups in any of the variables related to bone remodeling.
I-PRF has high concentrations of growth factors that may enhance tissue regeneration. TGF-β and PDGF have a direct correlation with the platelet content, while VEGF and fibroblast growth factor-2 have a poor correlation with the platelet content.
15Furthermore, the expression of collagen genes, platelets, and lymphocytes increases in the application of i-PRF.
16I-PRF has the highest concentration of platelets compared with other platelet concentrates,
9but it may not have adequate amounts of leukocytes to induce the release of growth factors and cytokines from the platelet concentrates and significantly affect the regenerative process.
Zeitounlouian et al.
17evaluated the efficacy of i-PRF for the preservation of bone and prevention of root resorption and showed that it had no significant effect on bone quality during canine retraction or the prevention of canine root resorption. Their results were in line with the present findings. Mu et al.
18evaluated the effects of PRF in combination with deproteinized bovine bone mineral on bone remodeling in sinus floor augmentation in rabbits. They reported a higher percentage of newly formed bone in the intervention group; however, the overall bone volume was the same in the two groups. They concluded that the application of i-PRF in combination with deproteinized bovine bone mineral accelerated angiogenesis, bone remodeling, and substitution of graft material. The difference between their results and the present findings may be due to the evaluation of rabbits in their study versus dogs in the present study. Cömert Kılıç et al.
19showed that the application of P-PRP and PRF along with bone grafting had no significant effect on bone formation and regeneration. Their results were in line with the present findings despite the use of different products and protocols.
Variations in the results can be due to differences in animal models, assessment periods, and biomaterial types. In the process of bone regeneration, biological events, including blood clotting, inflammatory reactions, and angiogenesis, occur along with cellular differentiation and mineralization.
19Furthermore, the presence of blood clots is important for postoperative healing since they are replaced with connective tissue and are responsible for dynamic bone remodeling in subsequent phases.
20In the first 2 weeks, the blood clots are still present, and then fibrous granulation tissue is formed, the number of inflammatory cells decreases, and osteoclastic activity increases.
20By the progression of angiogenesis, mesenchymal cells are differentiated to osteogenic cells that differentiate to osteoblasts. Finally, bone remodeling leads to new bone formation even in the short term.
Erdur et al.
21reported that the application of i-PRF induced the expression of pro-inflammatory cytokines, osteoclastic activity, and enhancement of OTM. An increase in the number of osteoclasts was also noted in the test group in the present study; however, it was not statistically significant. Kizildağ et al.
22evaluated new bone formation following autogenous bone grafting in combination with PRF in rabbit calvaria. They showed greater new bone formation and higher bone density in the autogenous bone + PRF group, compared with autogenous bone alone and the control group. Alhasyimi et al.
23evaluated the effects of A-PRF containing hydroxyapatite carbonate on bone remodeling and relapse in rabbits and reported an increase in the number of osteoblasts and a reduction in osteoclastic activity in the PRF group containing hydroxyapatite carbonate. The difference between their results and the present findings can be due to using different animals and also differences between A-PRF and i-PRF in levels and types of cytokines. Yashwant et al.
24showed that the application of PRF as a graft material or membrane at the decortication site enhanced wound healing. Miron et al.
25demonstrated that i-PRF was capable of releasing higher concentrations of growth factors, greater induction of fibroblasts, and higher production of PDGF, TGF-B, and type I collagen, compared with PRP. Rashid et al.
26evaluated the effects of PRP on the speed of OTM in dogs and showed a higher number of osteoclasts at the resorption site in the test group, indicating a higher speed of OTM in the PRP group. Furthermore, greater osteogenesis was noted in the PRP group. Their results were different from the present findings probably due to differences in sample size. Güleç et al.
27evaluated the effects of different concentrations of PRP on alveolar bone density and speed of OTM in rats and showed that injection of moderate and high concentrations of PRP decreased alveolar bone density in paradental tissues, increased osteoclastic activity, and enhanced OTM. PRF releases several growth factors such as PDGF, fibroblast growth factor, and VEGF. PDGF stimulates cell proliferation, and VEGF induces angiogenesis. Since OTM is an inflammatory process, the presence of leukocytes in PRF can enhance OTM. Cytokines, interleukins, and tissue necrosis factors that are also present in PRF regulate the immunological reactions involved in OTM as well. Nonetheless, platelet concentrates can have several biological effects such that a previous study showed that growth factors may inhibit the release of cytokines, suppress inflammation, and induce tissue regeneration.
28To further clarify the role of i-PRF in bone remodeling, the degree of inflammation should be assessed at both the injection and control sides. Che et al.,
29in a review study, reported that the application of PRF along with bone graft materials increases osteogenesis; however, some concerns still exist with respect to the acceleration of OTM.
The small sample size and evaluation of histological sections only at 1 time-point (63 days) due to the design of the study were among the limitations of this study. Future studies are recommended to immunohistochemically and radiographically assess the effects of platelet concentrates such as i-PRF and L-PRF on OTM, bone remodeling, and root resorption in a larger sample size.
Conclusion
PDL injection of i-PRF around the second premolars of dogs under orthodontic force had no significant effect on bone remodeling.
Financial support and sponsorship
Nil.
Conflicts of interest
The authors of this manuscript declare that they have no conflicts of interest, real or perceived, financial or non-financial in this article.
RavindraNEsthetics and Biomechanics in Orthodontics.2nd edEsthetics and Biomechanics in Orthodontics 2nd ed St Louis: Elsevier; 2015 p 85,229,259PerinettiGPaolantonioMD'AttilioMD'ArchivioDTripodiDFemminellaBAlkaline phosphatase activity in gingival crevicular fluid during human orthodontic tooth movement54856DavidovitchZTooth movement41150MeikleMCThe tissue, cellular, and molecular regulation of orthodontic tooth movement: 100 years after Carl Sandstedt22140DavidovitchZNicolayOFNganPWShanfeldJLNeurotransmitters, cytokines, and the control of alveolar bone remodeling in orthodontics41135KrishnanVDavidovitchZCellular, molecular, and tissue-level reactions to orthodontic force.Am J Orthod Dentofacial Orthop 2006;129:469Cellular, molecular, and tissue-level reactions to orthodontic force Am J Orthod Dentofacial Orthop 2006;129:469e1-32IntiniGThe use of platelet-rich plasma in bone reconstruction therapy495666MarxREPlatelet-rich plasma (PRP): What is PRP and what is not PRP?2258ChoukrounJGhanaatiSReduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients' own inflammatory cells, platelets and growth factors: The first introduction to the low speed centrifugation concept8795HeLLinYHuXZhangYWuHA comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro70713Dohan EhrenfestDMde PeppoGMDoglioliPSammartinoGSlow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): A gold standard to achieve for all surgical platelet concentrates technologies639SuCYKuoYPTsengYHSuCHBurnoufTIn vitro release of growth factors from platelet-rich fibrin (PRF): A proposal to optimize the clinical applications of PRF5661GianniniSCieloABonanomeLRastelliCDerlaCCorpaciFComparison between PRP, PRGF and PRF: Lights and shadows in three similar but different protocols92730ChowSCShaoJWangHLokhnyginaYSample Size Calculations in Clinical Research.3rd edSample Size Calculations in Clinical Research 3rd ed Boca Raton: CRC Press; 2018Abed SaidiZHAmirAliakbariSResearch Method in Medical and Health SciencesResearch Method in Medical and Health Sciences Tehran, Salemi: Tehran, Jame-e-Negar; 2014SerafiniGLopreiatoMLollobrigidaMLamazzaLMazzucchiGFortunatoLPlatelet rich fibrin (PRF) and its related products: Biomolecular characterization of the liquid fibrinogen1099ZeitounlouianTSZenoKGBradBAHaddadRAThree-dimensional evaluation of the effects of injectable platelet rich fibrin (i-PRF) on alveolar bone and root length during orthodontic treatment: A randomized split mouth trial92MuZHeQXinLLiYYuanSZouHEffects of injectable platelet rich fibrin on bone remodeling in combination with DBBM in maxillary sinus elevation: A randomized preclinical study731225Cömert KılıçSGüngörmüşMParlakSNHistologic and histomorphometric assessment of sinus-floor augmentation with beta-tricalcium phosphate alone or in combination with pure-platelet-rich plasma or platelet-rich fibrin201795967BayerEAGottardiRFedorchakMVLittleSRThe scope and sequence of growth factor delivery for vascularized bone tissue regeneration12940ErdurEAKarakaslıKOncuEOzturkBHakkıSEffect of injectable platelet-rich fibrin (i-PRF) on the rate of tooth movement28592KizildağATaşdemirUArabaciTÖzmenÖKizildağCAIyilikciBEvaluation of new bone formation using autogenous tooth bone graft combined with platelet-rich fibrin in calvarial defects16626AlhasyimiAAPudyaniPPAsmaraWAnaIDEnhancement of post-orthodontic tooth stability by carbonated hydroxyapatite-incorporated advanced platelet-rich fibrin in rabbits1128YashwantVABaluPKumarRSAmmayappanPMurugaboopathyVEffectiveness of platelet rich fibrin versus demineralized bone xenograft in periodontally accelerated osteogenic orthodontics1808MironRJFujioka-KobayashiMHernandezMKandalamUZhangYGhanaatiSInjectable platelet rich fibrin (i-PRF): Opportunities in regenerative dentistry?261927RashidAElSharabyFANassefEMMehanniSMostafaYAEffect of platelet-rich plasma on orthodontic tooth movement in dogs10210GüleçABakkalbaşıBÇCumbulAUsluÜAlevBYaratAEffects of local platelet-rich plasma injection on the rate of orthodontic tooth movement in a rat model: A histomorphometric study92104SebaounJDKantarciATurnerJWCarvalhoRSVan DykeTEFergusonDJModeling of trabecular bone and lamina dura following selective alveolar decortication in rats167988CheYLiPTianLWangMXiongRLeiXThe research progress of platelet-rich fibrin applications in orthodontic treatment5249